Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > ACTUAL EV with calcs
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by DayOfReckoningon May 13, 2016 8:56am
175 Views
Post# 24869412

RE:RE:RE:ACTUAL EV with calcs

RE:RE:RE:ACTUAL EV with calcsLets say $625M in EBITDA....

Q1 Interest expense was $68M or $272M annualized... The capital structure is inefficient and CXR should have raised more equity for AMCO aquisition. Now you have drug pricing in the crosshairs of politics for the next 6 months...

Selling the pop to $42 was a gift. Thank you rumor mill ;)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities